| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,406 |
8,261 |
$447K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,690 |
1,649 |
$139K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,031 |
1,182 |
$123K |
| W0037 |
|
3,128 |
3,128 |
$68K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,197 |
883 |
$58K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
291 |
271 |
$30K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,981 |
1,841 |
$29K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
503 |
453 |
$14K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
188 |
177 |
$12K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
391 |
360 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
713 |
638 |
$11K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
209 |
168 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
249 |
213 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
173 |
78 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
126 |
116 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
704 |
592 |
$5K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
274 |
235 |
$5K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
186 |
165 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
1,321 |
1,074 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
198 |
141 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
194 |
67 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
147 |
131 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
45 |
43 |
$3K |
| 87081 |
|
438 |
397 |
$2K |
| 90686 |
|
372 |
342 |
$2K |
| 87276 |
|
120 |
107 |
$2K |
| 87275 |
|
120 |
107 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
169 |
144 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
38 |
13 |
$1K |
| 90688 |
|
394 |
374 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
28 |
22 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
104 |
91 |
$871.38 |
| 80053 |
Comprehensive metabolic panel |
79 |
70 |
$755.15 |
| 81001 |
|
199 |
156 |
$554.22 |
| 0012A |
|
12 |
12 |
$476.04 |
| 87077 |
|
36 |
31 |
$355.08 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
12 |
$294.12 |
| 0011A |
|
13 |
13 |
$288.01 |
| A0425 |
Ground mileage, per statute mile |
18 |
12 |
$283.42 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
26 |
24 |
$223.33 |
| 90715 |
|
12 |
12 |
$209.20 |
| 80061 |
Lipid panel |
14 |
14 |
$187.46 |
| 90670 |
|
83 |
79 |
$169.96 |
| 90633 |
|
57 |
56 |
$61.26 |
| 90685 |
|
22 |
21 |
$47.28 |
| 90723 |
|
15 |
13 |
$0.00 |
| 90680 |
|
15 |
13 |
$0.00 |
| 90651 |
|
46 |
44 |
$0.00 |
| 90461 |
|
1,020 |
955 |
$0.00 |
| 90734 |
|
28 |
26 |
$0.00 |